| Total sample (n = 116) | Training set (n = 87) | Test set (n = 29) |
---|---|---|---|
Seizure n (%) | 20 (17.2) | 16 (18.4) | 4 (13.8) |
Complex migraine n (%) | 13 (11.2) | 8 (9.2) | 5 (17.2) |
Hypertensive encephalopathy n (%) | 7 (6.0) | 5 (5.7) | 2 (6.9) |
Psychogenic event / psychiatric disorder n (%) | 7 (6.0) | 6 (6.9) | 1 (3.4) |
Hypotension / syncope n (%) | 7 (6.0) | 5 (5.7) | 2 (6.9) |
Sepsis / infection n (%) | 7 (6.0) | 6 (6.9) | 1 (3.4) |
Adverse drug reaction n (%) | 6 (5.2) | 4 (4.6) | 2 (6.9) |
Space occupying lesion n (%) | 6 (5.2) | 4 (4.6) | 2 (6.9) |
Bell's palsy n (%) | 5 (4.3) | 4 (4.6) | 1 (3.4) |
Alcohol intoxication n (%) | 4 (3.4) | 2 (2.3) | 2 (6.9) |
Hypoglycemia n (%) | 3 (2.6) | 2 (2.3) | 1 (3.4) |
Dementia n (%) | 3 (2.6) | 3 (3.4) | 0 (0.0) |
Dehydration n (%) | 3 (2.6) | 3 (3.4) | 0 (0.0) |
Vestibular dysfunction n (%) | 3 (2.6) | 1 (1.1) | 2 (6.9) |
Peripheral neuropathy n (%) | 2 (1.7) | 2 (2.3) | 0 (0.0) |
Transient global amnesia n (%) | 2 (1.7) | 1 (1.1) | 1 (3.4) |
Parkinson’s disease n (%) | 2 (1.7) | 2 (2.3) | 0 (0.0) |
Multiple sclerosis n (%) | 2 (1.7) | 2 (2.3) | 0 (0.0) |
Hepatic encephalopathy n (%) | 2 (1.7) | 1 (1.1) | 1 (3.4) |
Other n (%) | 12 (10.3) | 10 (11.5) | 2 (6.9) |